Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Schmidt

Showing results (1-10 of 343) with videos related to

Pageof 35
Sort By:
Breast Care (Basel, Switzerland)|September 2, 2014
Chemotherapy in early breast cancer: when, how and which one?Marcus Schmidt
Breast Care (Basel, Switzerland)|April 7, 2016
Dose-Dense Chemotherapy in Metastatic Breast Cancer: Shortening the Time Interval for a Better Therapeutic IndexMarcus Schmidt
Journal Fur Gynakologische Endokrinologie (Osterreichische Ausg.)|August 25, 2020
[Targeted Therapy in Metastatic Breast Cancer-Which Molecular Tests Are Necessary?]Marcus Schmidt
Breast Care (Basel, Switzerland)|December 21, 2023
Which Patients Need Chemotherapy? From Pathological Risk Factors to Gene Signatures and Evaluation of Endocrine ResponseMarcus Schmidt
Critical Reviews in Food Science and Nutrition|December 28, 2020
Cereal beta-glucans: an underutilized health endorsing food ingredientMarcus Schmidt
Current Opinion in Obstetrics & Gynecology|December 14, 2019
Prognostic and predictive markers for adjuvant therapyMarcus Schmidt
Breast Care (Basel, Switzerland)|November 16, 2010
Node-Negative Breast Cancer: Which Patients Should Be Treated?Marcus Schmidt
Breast Care (Basel, Switzerland)|August 6, 2016
Palbociclib - from Bench to Bedside and BeyondMarcus Schmidt
Advances in Food and Nutrition Research|September 26, 2025
Non-starch carbohydrates as lever to improve cereal-based foods: The case of FODMAP and beta-glucansMarcus Schmidt
Geburtshilfe Und Frauenheilkunde|December 27, 2019
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast CancerNina Ditsch, Marcus Schmidt
Pageof 35

Showing results (1-10 of 343) with videos related to

Sort By:
Pageof 35
Breast Care (Basel, Switzerland)|September 2, 2014
Chemotherapy in early breast cancer: when, how and which one?Marcus Schmidt
Breast Care (Basel, Switzerland)|April 7, 2016
Dose-Dense Chemotherapy in Metastatic Breast Cancer: Shortening the Time Interval for a Better Therapeutic IndexMarcus Schmidt
Journal Fur Gynakologische Endokrinologie (Osterreichische Ausg.)|August 25, 2020
[Targeted Therapy in Metastatic Breast Cancer-Which Molecular Tests Are Necessary?]Marcus Schmidt
Breast Care (Basel, Switzerland)|December 21, 2023
Which Patients Need Chemotherapy? From Pathological Risk Factors to Gene Signatures and Evaluation of Endocrine ResponseMarcus Schmidt
Critical Reviews in Food Science and Nutrition|December 28, 2020
Cereal beta-glucans: an underutilized health endorsing food ingredientMarcus Schmidt
Current Opinion in Obstetrics & Gynecology|December 14, 2019
Prognostic and predictive markers for adjuvant therapyMarcus Schmidt
Breast Care (Basel, Switzerland)|November 16, 2010
Node-Negative Breast Cancer: Which Patients Should Be Treated?Marcus Schmidt
Breast Care (Basel, Switzerland)|August 6, 2016
Palbociclib - from Bench to Bedside and BeyondMarcus Schmidt
Advances in Food and Nutrition Research|September 26, 2025
Non-starch carbohydrates as lever to improve cereal-based foods: The case of FODMAP and beta-glucansMarcus Schmidt
Geburtshilfe Und Frauenheilkunde|December 27, 2019
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast CancerNina Ditsch, Marcus Schmidt
Pageof 35